Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses

Journal of Experimental Medicine

Volumn 184, Issue 1, 1996, Pages 41-50

  Prager, Elisabeth ^a   Sunder Plassmann, Raute ^a   Hansmann, Cornelia ^a   Koch, Christian ^a   Holter, Wolfgang ^a   Knapp, Walter ^a   Stockinger, Hannes ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Institute of Immunology VIRCC   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN;

ARTICLE; CELL ADHESION; DOWN REGULATION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD31; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BASE SEQUENCE; CATIONS, DIVALENT; CELL ADHESION MOLECULES; CELL AGGREGATION; CLONE CELLS; DNA PRIMERS; DOWN-REGULATION; HEPARIN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LIGANDS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030054635     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.1.41     Document Type: Article

References (49)

1. DeLisser, H.M., P.J. Newman, and S.M. Albelda. 1994. Molecular and functional aspects of PECAM-1/CD31. Immunol. Today. 15:490-495.
2. Muller, W.A., C.M. Ratti, S.L. McDonnell, and Z.A. Cohn. 1989. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J. Exp. Med. 170:399-414.
3. Newman, P.J., M.C. Berndt, J. Gorski, G.C. White II, S. Lyman, C. Paddock, and W.A. Muller. 1990. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science (Wash. DC). 247:1219-1222.
4. Stockinger, H., S.J. Gadd, R. Eher, O. Majdic, W. Schreiber, W. Kasinrerk, B. Strass, E. Schnabl, and W. Knapp. 1990. Molecular characterization and functional analysis of the leukocyte surface protein CD31. J. Immunol. 145:3889-3897.
5. Stockniger, H., W. Schreiber, O. Majdic, W. Holter, D. Maurer, and W. Knapp. 1992. Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family. Immunology. 75:53-58.
6. Simmons, D.L., C. Walker, C. Power, and R. Pigott. 1990. Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J. Exp. Med. 171:2147-2152.
7. Albelda, S.M., P.D. Oliver, L.H. Romer, and C.A. Buck. 1990. EndoCAM: a novel endothelial cell-cell adhesion molecule. J. Cell. Biol. 110:1227-1237.
8. Albelda, S.M., W.A. Muller, C.A. Buck, and P.J. Newman. 1991. Molecular and cellular properties of PECAM-1 (endo CAM/CD31): a novel vascular cell-cell adhesion molecule. J. Cell Biol. 114:1059-1068.
9. Muller, W.A., M.E. Berman, P.J. Newman, H.M. DeLisser, and S.M. Albelda. 1992. A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J. Exp. Med. 175:1401-1404.
10. DeLisser, H.M., H.C. Yan, P.J. Newman, W.A. Muller, C.A. Buck, and S.M. Albelda. 1993. Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J. Biol. Chem. 268: 16037-16046.
11. DeLisser, H.M., J. Chilkotowsky, H.-C. Yan, M.L. Daise, C.A. Buck, and S.M. Albelda. 1994. Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties. J. Cell Biol. 124:195-203.
12. Chen, W., W. Knapp, O. Majdic, H. Stockinger, G.A. Böhmig, and G.J. Zlabinger. 1994. Co-ligation of CD31 and Fc-γRII induces cytokine production in human monocytes. J. Immunol. 152:3991-3997.
13. Tanaka, Y., S.M. Albelda, K.J. Morgan, G.A. van Seventer, Y. Shimizu, W. Newman, J. Hallam, P.J. Newman, C.A. Buck, and S. Shaw. 1992. CD31 expressed on distinctive T cell subsets is a preferential amplifier of β1 integrin-mediated adhesion. J. Exp. Med. 176:245-253.
14. Berman, M.E., and W.A. Muller. 1995. Ligation of platelet/ endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). J. Immunol. 154:299-307.
15. Muller, W.A., S.A. Weigl, X. Deng, and D.M. Phillip. 1993. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178:449-460.
16. Vaporciyan, A.A., H.M. DeLisser, H.-C. Yan, I.I. Mendiguren, S.R. Thom, M.L. Jones, P.A. Ward, and S.M. Albelda. 1993. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science (Wash. DC) 262:1580-1582.
17. Bogen, S., J. Pak M. Garifallou, X. Deng, and W.A. Muller. 1994. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J. Exp. Med. 179:1059-1064.
18. Liao, F., H.K. Huynh, A. Eiroa, T. Greene, E. Polizzi, and W.A. Muller. 1995. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J. Exp. Med. 182: 1337-1343.
19. Torimoto, Y., D.M. Rothstein, N.H. Dang, S.F. Schlossman, and C. Morimoto. 1992. CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. J. Immunol. 148:388-396.
20. Zehnder, J.L., M. Shatsky, L.L.K. Leung, E.C. Butcher, J.L. McGregor, and L.J. Levitt. 1995. Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide. Blood. 85:1282-1288.
21. Aruffo, A., I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303-1313.
22. Kasinrerk, W., E. Fiebiger, I. Stefanová, T. Baumruker, W. Knapp, and H Stockinger. 1992. Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basìgin, and chicken HT7 molecule. J. Immunol. 149:847-854.
23. Subramani, S., R. Mulligan, and P. Berg. 1981. Expression of the mouse dihydrofolate reductase complementary deoxyribonucleic acid in simian virus 40 vectors. Mol. Cell. Biol. 1: 854-864.
24. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
25. Sunder-Plassmann, R., H. Breiteneder, K. Zimmermann, D. Strunk, O. Majdic, W. Knapp, and W. Holter. 1996. Single human T cells stimulated in the absence of feeder cells transcribe IL-2 and undergo long term clonal growth in response to defined mAb and cytokine stimulation. Blood. In press.
26. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
27. Kawasaki, E.S. 1990. Amplification of RNA. In PCR Protocols: A Guide to Methods and Applications. M.A. Innis, D.H. Gelfand, J.J. Sninsky, and T.J. White, editors. Academic Press, Inc., San Diego, CA. 21-27.
28. Melby, P.C., B.J. Darnell, and V.V. Tryon. 1993. Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J. Immunol. Methods. 159:235-244.
29. Tamura, G., M. Dailey, W. Gallatin, M. McGrath, I. Weismann, and E. Pillemer. 1984. Isolation of molecules recognized by monoclonal antibodies and antisera: the solid phase immunoisolation technique. Anal. Biochem. 136:458-464.
30. Cole, S.R., L.K. Ashman, and P.L. Ey. 1987. Biotinylation: an alternative to radioiodination for the identification of cell surface antigens in immunoprecipitates. Mol. Immunol. 24: 699-705.
31. Cerwenka, A., D. Bevec, O. Majdic, W. Knapp, and W. Holter. 1994. TGF-β1 is a potent inducer of human effector T cells. J. Immunol. 153:4367-4377.
32. Holter, W., F.S. Kalthoff, O. Majdic, and W. Knapp. 1993. Interleukin-4 production by the malignant cell line HUT78. Lymphokine Cytokine Res. 12:33-37.
33. Linsley, P.S., J. Bradshaw, M. Urnes, L. Grosmaire, and J.A. Ledbetter. 1993. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. J. Immunol. 150:3161-3169.
34. + T cells. Annu. Rev. Immunol. 12:635-673.
35. + hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood. 82:2649-2663.
36. Fawcett, J., C. Buckley, C.L. Holness, I.N. Bird, J.H. Spragg, J. Saunders, A. Harris, and D.L. Simmons. 1995. Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts. J. Cell Biol. 128:1229-1241.
37. Bogen, S.A., H.S. Baldwin, S.C. Watkins, S.M. Albelda, and A.K. Abbas. 1992. Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation. Am. J. Pathol. 141:843-854.
38. Bird, I.N., J.H. Spragg, A. Ager, and N. Matthews. 1993. Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology. 80:553-560.
39. 3, integrin involved in adhesion of leukocytes to endothelium. J. Cell Biol. 130:451-460.
40. Kirschbaum, N.E., R.J. Gumina, and P.J. Newman. 1994. Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain. Blood. 84:4028-4037.
41. Baldwin, H.S., H.M. Shen, H.-C. Yan, H.M. DeLisser, A. Chung, C. Mickanin, T. Trask, N.E. Kirschbaum, P.J. Newman, S.M. Albelda, and C.A. Buck. 1994. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development (Camb.). 120:2539-2553.
42. Yan, H.C., H.S. Baldwin, J. Sun, C.A. Buck, S.M. Albelda, and H.M. Delisser. 1995. Alternative splicing of a specific cytoplasmic exon alters the binding characteristics of murine platelet/endothelial cell adhesion molecule-1 (PECAM-1). J. Biol. Chem. 270:23672-23680.
43. Zehnder, J.L., K. Hirai, M. Shatsky, J.L. McGregor, L.J. Levitt, and L.L.K. Leung. 1992. The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes. J. Biol. Chem. 267: 5243-5249.
44. Linsley, P.S. 1995. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J. Exp. Med. 182:289-292.
45. Walunas, T.L., D.J. Lenschow, C.Y. Bakker, P.S. Linsley, G.J. Freeman, J.M. Green, C.B. Thompson, and J.A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:405-413.
46. Krummel, M.F., and J.P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459-465.
47. Gribben, J.G., G.J. Freeman, V.A. Boussiotis, P. Rennert, C.L. Jellis, E. Greenfield, M. Barber, V.A. Restivo Jr., X. Ke, G.S. Gray, and L.M. Nadler. 1995. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 92:811-815.
48. Liu, Y., and P.S. Linsley. 1992. Costimulation of T-cell growth. Curr. Opin. Immunol. 4:265-270.
49. Jenkins, M.K., and J.G. Johnson. 1993. Molecules involved in T-cell costimulation. Curr. Opin. Immunol. 5:361-367.